Faculty

Institution

Unit

Venue

Vanessa Sarli

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

NoneVanessa Sarli is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Vanessa Sarli

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer cells breast cancer breast oncology pathology tumor biology cancer research radiation oncology melanoma cancer biology cancer care cell biology molecular cancer cancer treatment oncogenes metastasis cellular therapy pharmacology therapeutic targets molecular diagnostics cancer detection prognostic biomarkers tumor cells anti-cancer agents photocarcinogenesis cancer imaging surgical oncology circulating tumor cells clinical research medicinal research cancer management immune checkpoint inhibitors medical mycology leukemia thoracic oncology tumor targeting nucleic acid biomarkers radiation therapy clinical radiation oncology cancer growth cellular senescence breast surgery cell proliferation immune checkpoint inhibition neoadjuvant chemotherapy tumor dna treatment response triple-negative breast cancer medical imaging biomedical analysis neuroradiology enzyme inhibition surgical pathology liver cancer clinical immunology parathyroid disease parathyroid glands treatment development evolution-based method biological evolution natural selection evolutionary dynamics cell culture therapy resistance molecular pathology cancer immunosurveillance biological microenvironments metastatic uveal melanoma pilot study circulating tumor dna precision oncology quantitative tumor modeling dual assessment usable model resistant cancer cells uveal melanoma metastatic

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 7438: Residual Disease on a Dish: A Practical Approach to Deep Intrinsic Resistance in Melanoma. Cancer Research (2026)

metastasispathologyresidual diseasetumor biologyintrinsic resistancemelanomadermatologyphotocarcinogenesisabstract 7438tumor microenvironment

A Phenotype-Based Cell Culture Model of Melanoma Cells That Persist as Residual Disease After Therapies Leading to Recurrence. Research Square (2026)

melanoma cellsresidual diseasebiological microenvironmentstumor biologycell proliferationcell biologymelanomadermatologycellular therapyphotocarcinogenesiscancer cellscell researchtumor microenvironment

Response to Neoadjuvant Chemotherapy in Both the Breast and Lymph Nodes in Patients With Inflammatory Breast Cancer.. Journal of Clinical Oncology (2026)

breast oncologyimmunologycancer careoncologybreast cancer

Abstract A010: A Cell Culture Model of Quiescent Melanoma Cell State That Governs Cancer Evolution, Therapy Resistance, and Recurrence/Metastasis. Cancer Research (2025)

oncogenesmetastasiscell culture modeltumor biologycancer evolutioncell biologymelanomaphotocarcinogenesiscancer researchcancer discoveryabstract a010systems biologycancer cellscell researchoncologycancer biology

Abstract P1-01-28: Molecular Residual Disease Precedes Radiographic Confirmation of Recurrence in Patients With Stage III Inflammatory Breast Cancer. Clinical Cancer Research (2025)

breast oncologypathologyabstract p1-01-28molecular pathologyimmunologymolecular cancercancer discoverycancer letteroncologybreast cancer

Abstract P3-07-13: Preoperative Predictors of Nodal Pcr for Potential De-Escalation of Axillary Surgery in Inflammatory Breast Cancer. Clinical Cancer Research (2025)

breast oncologypathologysurgeryaxillary surgerysurgical oncologynodal pcrinflammatory breast cancerbreast surgerycancer careoncologybreast cancer

Is Ctc Pdl-1 Expression Predictive of Response After Neoadjuvant Immunotherapy in Stage Iib-IV Melanoma?. The Journal of Liquid Biopsy (2025)

oncogenespathologycancer immunotherapyimmunologymelanomaimmunotherapycellular therapystage iib-iv melanomacancer cellstherapeutic vaccinesimmune checkpoint inhibitorsoncologyneoadjuvant immunotherapy

Abstract 3385: Modeling Evolutionary Fitness in Resistant Cancers Based on a Common Adaptability Trait. Cancer Research (2024)

biostatisticsadaptationbiological evolutionabstract 3385theoretical biologymathematical biologyevolutionary dynamicscommon adaptability traitnatural selectiondrug resistanceevolutionary fitnesssystems biologyevolution-based method

Abstract B010: Prognostic Value of Circulating Tumor Cells in Stage III and IV Melanoma: A Systematic Review and Meta-Analysis. Clinical Cancer Research (2024)

pathologyradiation oncologyprognostic biomarkersabstract b010melanomaiv melanomacancer researchmolecular diagnosticstumor cellscancer cellsoncology

Abstract Po5-16-05: Integrating Circulating Tumor Cells (Ctcs) and Cell-Free Dna (Cfdna) Signatures for Monitoring Treatment Response in Stage III/IV Inflammatory Breast Cancer. Cancer Research (2024)

breast oncologyprognostic biomarkerstumor biologycancer biologytreatment responsecell-free dnaimmunologycell biologymolecular cancercellular therapymolecular diagnosticstumor cellscancer immunosurveillancebiomarkerscancer cellstumor microenvironmentbreast cancernucleic acid biomarkers

1
2
3
4
10 / page

Vanessa Sarli

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

NoneVanessa Sarli is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Vanessa Sarli

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 7438: Residual Disease on a Dish: A Practical Approach to Deep Intrinsic Resistance in Melanoma. Cancer Research (2026)

metastasispathologyresidual diseasetumor biologyintrinsic resistancemelanomadermatologyphotocarcinogenesisabstract 7438tumor microenvironment

A Phenotype-Based Cell Culture Model of Melanoma Cells That Persist as Residual Disease After Therapies Leading to Recurrence. Research Square (2026)

Response to Neoadjuvant Chemotherapy in Both the Breast and Lymph Nodes in Patients With Inflammatory Breast Cancer.. Journal of Clinical Oncology (2026)

breast oncologyimmunologycancer careoncologybreast cancer

Abstract A010: A Cell Culture Model of Quiescent Melanoma Cell State That Governs Cancer Evolution, Therapy Resistance, and Recurrence/Metastasis. Cancer Research (2025)

Abstract P1-01-28: Molecular Residual Disease Precedes Radiographic Confirmation of Recurrence in Patients With Stage III Inflammatory Breast Cancer. Clinical Cancer Research (2025)

breast oncologypathologyabstract p1-01-28molecular pathologyimmunologymolecular cancercancer discoverycancer letteroncologybreast cancer

Abstract P3-07-13: Preoperative Predictors of Nodal Pcr for Potential De-Escalation of Axillary Surgery in Inflammatory Breast Cancer. Clinical Cancer Research (2025)

breast oncologypathologysurgeryaxillary surgerysurgical oncologynodal pcrinflammatory breast cancerbreast surgerycancer careoncologybreast cancer

Is Ctc Pdl-1 Expression Predictive of Response After Neoadjuvant Immunotherapy in Stage Iib-IV Melanoma?. The Journal of Liquid Biopsy (2025)

oncogenespathologycancer immunotherapyimmunologymelanomaimmunotherapycellular therapystage iib-iv melanomacancer cellstherapeutic vaccinesimmune checkpoint inhibitorsoncologyneoadjuvant immunotherapy

Abstract 3385: Modeling Evolutionary Fitness in Resistant Cancers Based on a Common Adaptability Trait. Cancer Research (2024)

Abstract B010: Prognostic Value of Circulating Tumor Cells in Stage III and IV Melanoma: A Systematic Review and Meta-Analysis. Clinical Cancer Research (2024)

pathologyradiation oncologyprognostic biomarkersabstract b010melanomaiv melanomacancer researchmolecular diagnosticstumor cellscancer cellsoncology

1
2
3
4
10 / page